Cite
Gündüz S, Göksu SS, Arslan D, et al. Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab. Mol Clin Oncol. 2015;3(5):1109-1112doi: 10.3892/mco.2015.610.
Gündüz, S., Göksu, S. S., Arslan, D., Tatli, A. M., Uysal, M., Gündüz, U. R., Sevinç, M. M., Coşkun, H. S., Bozcuk, H., Mutlu, H., & Savas, B. (2015). Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab. Molecular and clinical oncology, 3(5), 1109-1112. https://doi.org/10.3892/mco.2015.610
Gündüz, Seyda, et al. "Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab." Molecular and clinical oncology vol. 3,5 (2015): 1109-1112. doi: https://doi.org/10.3892/mco.2015.610
Gündüz S, Göksu SS, Arslan D, Tatli AM, Uysal M, Gündüz UR, Sevinç MM, Coşkun HS, Bozcuk H, Mutlu H, Savas B. Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab. Mol Clin Oncol. 2015 Sep;3(5):1109-1112. doi: 10.3892/mco.2015.610. Epub 2015 Jul 21. PMID: 26623060; PMCID: PMC4534854.
Copy
Download .nbib